Heterobicyclic compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 405/12 (2006.01) A61K 31/35 (2006.01) A61K 31/445 (2006.01) A61K 31/495 (2006.01) A61K 31/675 (2006.01) C07D 307/79 (2006.01) C07D 307/80 (2006.01) C07D 311/22 (2006.01) C07D 311/30 (2006.01) C07D 311/32 (2006.01) C07D 311/60 (2006.01) C07D 335/06 (2006.01) C07D 401/12 (2006.01) C07D 405/04 (2006.01) C07D 405/14 (2006.01) C07D 407/12 (2006.01) C07D 409/00 (2006.01) C07D 409/04 (2006.01) C07F 9/547 (2006.01) C07F 9/6558 (2006.01)

Patent

CA 2090156

-189- ABSTRACT Heterobicyclic Compounds There are disclosed compounds of the general formula Image The heteroatom X is preferably oxygen, but may have other values. The group W is preferably a carbonyl group, but may have other values. The preferred heterocyclic ring is thus a 4-oxo-4H-1-benzopyran ring. This may have a wide range of R2, R3, R6 and R7 substituents. Y is a linking group, chosen from a wide range, but including -COO- , -CONH- , -O- , -SO2- and -SO2NH-. Z is an alkylene chain, and B is a complex amine. These compounds and their prodrugs, enantiomers, diastereoisomers, N-oxides and pharmaceutically acceptable salts are useful for the treatment of hypertension and urinary tract troubles associated with benign prostatic hypertrophy, and for the treatment of other diseases.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterobicyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterobicyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterobicyclic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2054776

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.